Comprehensive Investigation into the Role of Ubiquitin-Conjugating Enzyme E2S in Melanoma Development

Ping Wang,Yong Li,Yangyang Ma,Xiaoyan Zhang,Zhao Li,Wenzhong Yu,Mengyan Zhu,Jiaqi Wang,Yongping Xu,Aie Xu
DOI: https://doi.org/10.1016/j.jid.2020.05.113
IF: 7.59
2021-02-01
Journal of Investigative Dermatology
Abstract:Ubiquitin conjugating enzyme E2S (UBE2S) is involved in protein degradation and signal transduction, but its function in the development of melanoma is unclear. We focused on the role of UBE2S on melanoma development both in vitro and in vivo. UBE2S was overexpressed in malignant melanoma cells and tissues, and UBE2S expression was significantly different between tumor node metastasis staging T4 and T1/T2/T3. We designed UBE2S shRNA (shUBE2S) and transfected it into A375, SK-MEL-28 and MUM-2B cells using lentivirus. By whole genome filtering, 247 genes and 265 genes were up- and downregulated in shUBE2S-treated melanoma, respectively; these genes were mainly involved in immune reactions, apoptosis, DNA damage repair and cell movement. The proliferation of melanoma cells was inhibited, apoptosis was increased and cell cycle was arrested in G1/S in shUBE2S-treated melanoma. Expression of epithelial to mesenchymal transition (EMT) related proteins were significantly suppressed, and tumor growth was also suppressed in shUBE2S BALB/C nude mice. shUBE2S treatment may cause cell cycle arrest inG1/S phase, inhibit proliferation, induce apoptosis and suppress tumor growth through DNA damage repair, EMT inhibition, AKT-mTOR pathway, NF-κB signaling and immune reactions, which provides a comprehensive understanding of the role of UBE2S in melanoma development and the need for advanced clinical research into UBE2S.
dermatology
What problem does this paper attempt to address?